HealthEquity (NASDAQ:HQY) EVP Sells $142,080.00 in Stock

by · The Cerbat Gem

HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) EVP Delano Ladd sold 1,500 shares of the stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Delano Ladd also recently made the following trade(s):

  • On Thursday, November 20th, Delano Ladd sold 1,500 shares of HealthEquity stock. The stock was sold at an average price of $104.56, for a total value of $156,840.00.
  • On Monday, October 20th, Delano Ladd sold 1,500 shares of HealthEquity stock. The shares were sold at an average price of $92.07, for a total transaction of $138,105.00.

HealthEquity Stock Down 1.2%

Shares of NASDAQ:HQY traded down $1.09 during trading on Tuesday, hitting $92.69. 719,400 shares of the company were exchanged, compared to its average volume of 994,470. The firm’s 50 day moving average price is $97.24 and its 200-day moving average price is $96.19. HealthEquity, Inc. has a 12-month low of $74.07 and a 12-month high of $116.65. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The stock has a market capitalization of $7.92 billion, a P/E ratio of 42.52, a PEG ratio of 1.38 and a beta of 0.18.

HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same period last year, the business earned $0.78 EPS. HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on HQY shares. JPMorgan Chase & Co. boosted their price objective on HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Barrington Research reiterated an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. BTIG Research reiterated a “buy” rating and set a $130.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $120.27.

Read Our Latest Stock Report on HQY

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HQY. Hsbc Holdings PLC boosted its position in shares of HealthEquity by 14.7% during the 1st quarter. Hsbc Holdings PLC now owns 3,089 shares of the company’s stock worth $273,000 after purchasing an additional 395 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new stake in HealthEquity during the first quarter worth about $65,000. Martingale Asset Management L P acquired a new position in HealthEquity during the first quarter worth about $248,000. Price T Rowe Associates Inc. MD increased its holdings in HealthEquity by 995.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after buying an additional 580,988 shares in the last quarter. Finally, CW Advisors LLC acquired a new stake in shares of HealthEquity during the 1st quarter valued at approximately $289,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

(Get Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

See Also